Comparison of outcomes in optimally-cytoreduced ovarian cancer patients receiving postoperative intraperitoneal chemotherapy vs intravenous dose-dense chemotherapy without bevacizumab.
Saved in:
| Title: | Comparison of outcomes in optimally-cytoreduced ovarian cancer patients receiving postoperative intraperitoneal chemotherapy vs intravenous dose-dense chemotherapy without bevacizumab. |
|---|---|
| Authors: | Schlappe, B.1, O'Cearbhaill, R.1, Zhou, Q.1, Iasonos, A.1, Mueller, J.J.1, Zivanovic, O.1, Gardner, G.J.1, Long Roche, K.1, Sonoda, Y.1, Chi, D.S.1 |
| Source: | Gynecologic Oncology. Jun2017 Supplement 1, Vol. 145, p136-136. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00908258 |
|---|---|
| DOI: | 10.1016/j.ygyno.2017.03.317 |
